Given the results of ODYSSEY, FOURIER, and others, as a lipid/atherosclerosis specialist what is your take home about what the appetite should be for using PCSK9 inhibitors to lower LDL-C levels beyond ESC and AHA recommended thresholds of 70 mg/dL?

Given the results of ODYSSEY, FOURIER, and others, as a lipid/atherosclerosis specialist what is your take home about what the appetite should be for using PCSK9 inhibitors to lower LDL-C levels beyond ESC and AHA recommended thresholds of 70 mg/dL?

CLICK HERE FOR CME CREDIT

Given the results of ODYSSEY, FOURIER, and others, as a lipid/atherosclerosis specialist what is your take home about what the appetite should be for using PCSK9 inhibitors to lower LDL-C levels beyond ESC and AHA recommended thresholds of 70 mg/dL?

 

Created by

CMEducation Resources IQ&A Cardiovascular Intelligence Zone | The Medical Cardiology, Interventional Cardiology, Lipid Medicine, Atherosclerosis and Diabetes Specialist's Perspective

Presenter

Stephen Nicholls, MD

Stephen Nicholls, MD

SAHMRI Deputy Director and Heart Foundation Heart Health Theme Leader Professor of Cardiology University of Adelaide Consultant Cardiologist Royal Adelaide Hospital Adelaide, Australia